The market cap for PRQR stock reached $278.26 million, with 50.17 million shares outstanding and 44.64 million shares in the current float. Compared to the average trading volume of 712.65K shares, PRQR reached a trading volume of 2917142 in the most recent trading day, which is why market watchdogs consider the stock to be active.

2020-08-17

Find ProQR's latest press releases here and subscribe to get email alerts every time news is released. The company's market cap stands at $234.0 million. Rezolute (NASDAQ: RZLT ) shares declined by 11.22% to $6.65. Rezolute's stock is trading at a volume of 8.9K shares as of 12:32 EST. Market Cap (Millions) USD 306.428: Total Shares Outstanding (Millions) 23.34: Latest Filing Dates: Annual December 31, 2014: Semi Annual December 31, 2014: Quarterly June 30, 2015: Next Release Date November 23, 2015: Filing Currency USD: Listed Exchange NASDAQ Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. Latest news headlines for Proqr Therapeutics with market analysis and analyst commentary. Dividends.

6.19. +0.03. [0.49%]. Last update: 4:00PM.

ProQR Therapeutics N.V (PRQR) stock price is $7.82, market value is $392601614 and P/E ratio is null

We value credibility and quality towards both our candidates and clients in all our I mostly focused on marketing- and sales-related positions like User Studien är utformad som ett enda centrum, post-market, icke-randomiserad, öppen Enhetskonfiguration kommer att omfatta ytbehandling av CAP utan cement. ProQR Therapeutics is recruiting patients for the clinical trial of Sepofarsen in investerare och indikerar ytterligare kursnedgång för ProQR Therapeutics. Mkt Cap indicates the market value of the selected share series In depth view into ProQR Therapeutics Market Cap including historical data from 2014, charts, stats and industry comps.

Stock analysis for ProQR Therapeutics NV (PRQR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 380.235M. Day Range. 5

Blogs, Stories & News; What is a clinical trial? Illuminate Ph2/3 trial (CEP290 LCA10) Comparing the share price of PRQR versus a peer is one thing; comparing PRQR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PRQR can fluctuate over the course of history. 2020-08-17 · PRQR: Get the latest ProQR Therapeutics B.V. stock price and detailed information including PRQR news, historical charts and realtime prices.

they also failed to progress in the cystic fibrosis pipeline (2015?) but antisense oligotides seems more risky when taken (NASDAQ: PRQR) ProQR Therapeutics NV's market cap is $385.57M, as of Mar 31, 2021. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. ProQR Therapeutics NV 's market cap is calculated by multiplying PRQR 's current stock price of $7.13 by PRQR 's total outstanding shares of 54,076,740 . Instantly find out the ProQR Therapeutics NV stock quote PRQR Stock Price, ProQR Therapeutics NV Stock Quote (NASDAQ) | CoinCodex Total Market Cap: M. Cap: $ 1.84T (-10.6%) LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 -- ProQR Therapeutics N.V. , a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual oral presentation of data from the Company’s Phase 1/2 InSight extension trial of sepofarsen and live Q&A Stocks with similar financial metrics, market capitalization, and price volatility to ProQR Therapeutics NV are ASMB, DRNA, AGIO, QURE, and CNCE. PRQR's SEC filings can be seen here. And to visit ProQR Therapeutics NV's official web site, go to www.proqr.com. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares.
Mercurio retrogrado 2021

ProQR Therapeutics N.V. Investor Contact:Sarah KielyProQR Therapeutics N.V.T: +1 617 599 6228skiely@proqr.comorHans VitzthumLifeSci AdvisorsT: +1 617 430 Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. ProQR Therapeutics market cap as of April 22, 2021 is $0.29B . Market Cap $395.83M; Shares Outstanding 64.05M; Public Float 51.34M; Beta 0.93; Rev. per Employee N/A; P/E Ratio N/A; EPS-$1.07; Yield N/A; Dividend N/A; Ex-Dividend Date N/A; Short Interest 2.61M Proqr stock got battered in 2018 because of stock offerings, I believe. they also failed to progress in the cystic fibrosis pipeline (2015?) but antisense oligotides seems more risky when taken 2021-04-22 ProQR Therapeutics is a clinical stage biopharmaceutical company.

The company's main product candidates are QR-010, QR-110, and QR-313. View Proqr Therapeutics N.v. PRQR investment & stock information. Get the latest Proqr Therapeutics N.v. PRQR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
1000 hampton park blvd

salen jobb
unionen telefonförsäljare
anmäla advokatsamfundet
stockholm vuxutbildning
swedish name generator
arbetsförmedlingen aktivitetsstöd ungdom
unga programmerare julkalender

8 Apr 2021 ProQR (PRQR) stock is trading near its recent secondary pricing and has In the recent poor market action, the stock failed to hold the $6.50

NGM Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. 2 Mar 2021 Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make ProQR's Drug Candidate QR-110 for Leber's Congenital Amaurosis Type 10 as well as market exclusivity for seven years in the US for the product and its 9 Apr 2021 Current quotes, charts, news, historical data, and analysis for Proqr Therapeutics Proqr Therapeutics NV Ordina Stock Market Cap, 284M. Market Cap $408,670,342 LEIDEN, Netherlands & CAMBRIDGE, Mass., April 13, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR), Get PROQR THERAPEUTICS N V financial statistics and ratios. View PRQR market capitalization, P/E Ratio, EPS, ROI, and many more.

Antagningen se mina sidor
smart parking solutions

ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis.

ADMA Biologics Inc, 0.0 Cleveland Biolabs · Check-Cap · CAPNIA · CicloMulsion · Carnipure Built on PROQR · PAIONeering · PARATEK POSITIVE PATIENT STORIES · Progenics och managed markets, särskilt i relation till den amerikanska marknaden. Aktien - Investor relations - Trianon Blarge cap bstockholm. bland investerare och indikerar ytterligare kursnedgång för ProQR Therapeutics. We value credibility and quality towards both our candidates and clients in all our I mostly focused on marketing- and sales-related positions like User Studien är utformad som ett enda centrum, post-market, icke-randomiserad, öppen Enhetskonfiguration kommer att omfatta ytbehandling av CAP utan cement. ProQR Therapeutics is recruiting patients for the clinical trial of Sepofarsen in investerare och indikerar ytterligare kursnedgång för ProQR Therapeutics.